One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.33590/emjoncol/ryqk1664
Copy DOI
Export
Save
Share
Cite Journal: EMJ Oncology |  Publication Date: Dec 4, 2024 |
 License type: cc-by-nc |
This infographic, the second in a three-part series, explores the prevalence of ESR1 mutations in patients with ER+/HER2- advanced breast cancer, as well as frequency of testing for ESR1 mutations in the metastatic setting; liquid biopsy as testing methodology; and ASCO, NCCN, and ESMO guidelines related to ESR1 mutations.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
